Resonance Specialities Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 995985,
    "name": "Resonance Speci.",
    "stock_name": "Resonance Speci.",
    "full_name": "Resonance Specialities Ltd",
    "name_url": "stocks-analysis/resonance-speci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "112.85",
    "chg": 6.15,
    "chgp": "5.76%",
    "dir": 1,
    "prev_price": "106.70",
    "mcapval": "121.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524218,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE486D01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "16.26 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/resonance-speci-995985-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Resonance Speci. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resonance-speci-overvalued-or-undervalued-3745564",
        "imagepath": "",
        "date": "2025-12-04 08:39:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Current Valuation Metrics and Financial Health</strong></p>\n<p>As of early December 2025, Resonance Speci. trades at a price-to-earnings (PE) ratio of approximately 15.15, which is notably moderate within the specialty chemicals industry. The price-to-book value stands at 1.71, indicating that the stock is priced at a reasonable premium over its net asset value. Enterprise value (EV) multiples such as EV to EBIT and EV to EBITDA are 11.44 and 10.15 respectively, reflecting a balanced valuation relative to earnings before interest and taxes and earnings before interest, taxes, depreciation, and amortisation.</p>\n<p>The company’s PEG ratio, a key indicator that adjusts the PE ratio for earnings growth, is impressively low at 0.23. This suggests that the stock is undervalued relative to its exp..."
      },
      {
        "title": "Why is Resonance Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-resonance-speci-fallingrising-3732162",
        "imagepath": "",
        "date": "2025-11-27 00:41:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Gains Driven by Positive Quarterly Performance</strong></p>\n<p>Resonance Specialities has experienced a notable gain over the past week, with the stock appreciating by 4.31%, significantly outperforming the Sensex’s 0.50% rise during the same period. This short-term momentum is further underscored by a three-day consecutive gain, during which the stock has delivered a 5.3% return. Such gains suggest renewed investor interest, likely buoyed by the company’s consistent positive results over the last five quarters.</p>\n<p>The company’s latest financials reveal encouraging growth in net sales, which have increased by 21.04% to ₹42.80 crores in the most recent six-month period. Additionally, the return on capital employed (ROCE) stands at a robust 13.75%, the highest recorded in the ha..."
      },
      {
        "title": "Resonance Specialities Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/resonance-specialities-forms-death-cross-signalling-potential-bearish-trend-3729498",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ResonanceSpecia_dealthcross_3729498.png",
        "date": "2025-11-25 18:01:24",
        "description": "Resonance Specialities, a player in the Specialty Chemicals sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price trajectory over the longer term."
      },
      {
        "title": "Is Resonance Speci. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resonance-speci-overvalued-or-undervalued-3716763",
        "imagepath": "",
        "date": "2025-11-20 08:06:52",
        "description": "As of 19 November 2025, the valuation grade for Resonance Speci. has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 14.61, an EV to EBITDA of 9.79, and a PEG ratio of 0.23, which suggests that the stock may be undervalued relative to its growth prospects.\n\nIn comparison to its peers, Resonance Speci. has a PE ratio that is significantly lower than Solar Industries, which stands at 94.38, and Gujarat Fluoroch at 56.8, both of which are considered very expensive. This positions Resonance Speci. favorably within the specialty chemicals sector, especially considering its solid ROCE of 15.09% and ROE of 11.32%. Despite recent stock performance lagging behind the Sensex over the past year, the long-term return of 378.54% over the last decade highlights its potential for growth...."
      },
      {
        "title": "Is Resonance Speci. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resonance-speci-overvalued-or-undervalued-3713619",
        "imagepath": "",
        "date": "2025-11-19 08:09:34",
        "description": "As of 18 November 2025, the valuation grade for Resonance Speci. has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, supported by a PE ratio of 14.26, an EV to EBITDA of 9.55, and a PEG ratio of 0.22, all of which are favorable compared to its peers. \n\nIn the peer comparison, Resonance Speci. stands out against companies like Godrej Industries, which has a significantly higher PE ratio of 37.03, and Solar Industries, which is categorized as very expensive with a PE ratio of 94.24. Despite recent underperformance relative to the Sensex, with a year-to-date return of -4.79% compared to the Sensex's 8.36%, the attractive valuation metrics suggest that Resonance Speci. presents a compelling investment opportunity at its current price of 92.45...."
      },
      {
        "title": "Is Resonance Speci. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resonance-speci-overvalued-or-undervalued-3709896",
        "imagepath": "",
        "date": "2025-11-18 08:24:01",
        "description": "As of 17 November 2025, the valuation grade for Resonance Speciality has moved from attractive to fair. The company is currently fairly valued based on its financial ratios, which include a PE ratio of 14.59, an EV to EBITDA of 9.77, and a PEG ratio of 0.23. In comparison to its peers, Resonance Speciality's valuation appears reasonable, especially when contrasted with Solar Industries, which has a PE ratio of 95.31, and Gujarat Fluoroch, with a PE of 57.85, both of which are considered very expensive.\n\nDespite the recent grade change, Resonance Speciality has shown a strong return over the long term, with a 10-year return of 383.89%, although it has underperformed against the Sensex in the shorter term, particularly with a year-to-date return of -2.57% compared to the Sensex's 8.72%. Overall, the company remains fairly valued in the current market context...."
      },
      {
        "title": "Why is Resonance Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-resonance-speci-fallingrising-3676896",
        "imagepath": "",
        "date": "2025-11-06 22:37:48",
        "description": "As of 06-Nov, Resonance Specialities Ltd is experiencing a decline in its stock price, currently at Rs 90.86, which reflects a decrease of Rs 4.04 or 4.26%. The stock has been underperforming, having lost 7.15% over the last three days and is trading below all key moving averages, indicating a bearish trend. Additionally, the stock's performance over the past week shows a decline of 6.21%, and it has underperformed its sector by 3.14% today. The delivery volume has also decreased significantly, falling by 28.5% against the 5-day average, suggesting reduced investor participation. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, the Sensex has shown a modest decline of 1.30% over the past week, which contrasts with Resonance Specialities' sharper drop. While the benchmark has gained 1.86% ..."
      },
      {
        "title": "Is Resonance Speci. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resonance-speci-overvalued-or-undervalued-3674227",
        "imagepath": "",
        "date": "2025-11-06 08:09:24",
        "description": "As of 4 November 2025, the valuation grade for Resonance Speci. has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 14.64, an EV to EBITDA of 7.57, and a PEG ratio of 0.23, all of which suggest that the stock is trading at a discount relative to its earnings growth potential.\n\nIn comparison to its peers, Resonance Speci. stands out favorably against companies like Godrej Industries, which has a PE ratio of 36.97 and an EV to EBITDA of 29.44, and Solar Industries, which is deemed very expensive with a PE ratio of 97.69. Despite recent underperformance relative to the Sensex, with a YTD return of -2.27% compared to the Sensex's 6.81%, the attractive valuation metrics imply that Resonance Speci. may present a compelling investment opportunity moving forward...."
      }
    ],
    "total": 145,
    "sid": "995985",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/resonance-specialities-995985"
  },
  "announcements": [
    {
      "caption": "Re-Lodgement Of Transfer Request Of Physical Shares.",
      "datetime": "20-Jan-2026",
      "details": "Re-lodgement of transfer request of physical shares.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 05/02/2026 Inter-Alia To Consider And Approve The Unaudited Financial Results For The 3Rd Quarter Ended December 31 2025.",
      "datetime": "13-Jan-2026",
      "details": "Resonance Specialties Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve the unaudited financial results for the 3rd quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Update on board meeting",
      "datetime": "13-Jan-2026",
      "details": "Resonance Specialties Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve Board Meeting Intimation for Intimation Of Board Meeting To Be Held on 04/02/2026 Inter-Alia To Consider And Approve The Unaudited Financial Results For The 3rd Quarter Ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Resonance Specialities Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Jul 25",
          "dt": "2025-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Resonance Speci. overvalued or undervalued?

2025-12-04 08:39:22

Current Valuation Metrics and Financial Health As of early December 2025, Resonance Speci. trades at a price-to-earnings (PE) ratio of approximately 15.15, which is notably moderate within the specialty chemicals industry. The price-to-book value stands at 1.71, indicating that the stock is priced at a reasonable premium over its net asset value. Enterprise value (EV) multiples such as EV to EBIT and EV to EBITDA are 11.44 and 10.15 respectively, reflecting a balanced valuation relative to earnings before interest and taxes and earnings before interest, taxes, depreciation, and amortisation. The company’s PEG ratio, a key indicator that adjusts the PE ratio for earnings growth, is impressively low at 0.23. This suggests that the stock is undervalued relative to its exp...

Why is Resonance Speci. falling/rising?

2025-11-27 00:41:25

Short-Term Gains Driven by Positive Quarterly Performance Resonance Specialities has experienced a notable gain over the past week, with the stock appreciating by 4.31%, significantly outperforming the Sensex’s 0.50% rise during the same period. This short-term momentum is further underscored by a three-day consecutive gain, during which the stock has delivered a 5.3% return. Such gains suggest renewed investor interest, likely buoyed by the company’s consistent positive results over the last five quarters. The company’s latest financials reveal encouraging growth in net sales, which have increased by 21.04% to ₹42.80 crores in the most recent six-month period. Additionally, the return on capital employed (ROCE) stands at a robust 13.75%, the highest recorded in the ha...

Resonance Specialities Forms Death Cross Signalling Potential Bearish Trend

2025-11-25 18:01:24

Resonance Specialities, a player in the Specialty Chemicals sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price trajectory over the longer term.

Is Resonance Speci. overvalued or undervalued?

2025-11-20 08:06:52

As of 19 November 2025, the valuation grade for Resonance Speci. has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 14.61, an EV to EBITDA of 9.79, and a PEG ratio of 0.23, which suggests that the stock may be undervalued relative to its growth prospects. In comparison to its peers, Resonance Speci. has a PE ratio that is significantly lower than Solar Industries, which stands at 94.38, and Gujarat Fluoroch at 56.8, both of which are considered very expensive. This positions Resonance Speci. favorably within the specialty chemicals sector, especially considering its solid ROCE of 15.09% and ROE of 11.32%. Despite recent stock performance lagging behind the Sensex over the past year, the long-term return of 378.54% over the last decade highlights its potential for growth....

Is Resonance Speci. overvalued or undervalued?

2025-11-19 08:09:34

As of 18 November 2025, the valuation grade for Resonance Speci. has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, supported by a PE ratio of 14.26, an EV to EBITDA of 9.55, and a PEG ratio of 0.22, all of which are favorable compared to its peers. In the peer comparison, Resonance Speci. stands out against companies like Godrej Industries, which has a significantly higher PE ratio of 37.03, and Solar Industries, which is categorized as very expensive with a PE ratio of 94.24. Despite recent underperformance relative to the Sensex, with a year-to-date return of -4.79% compared to the Sensex's 8.36%, the attractive valuation metrics suggest that Resonance Speci. presents a compelling investment opportunity at its current price of 92.45....

Is Resonance Speci. overvalued or undervalued?

2025-11-18 08:24:01

As of 17 November 2025, the valuation grade for Resonance Speciality has moved from attractive to fair. The company is currently fairly valued based on its financial ratios, which include a PE ratio of 14.59, an EV to EBITDA of 9.77, and a PEG ratio of 0.23. In comparison to its peers, Resonance Speciality's valuation appears reasonable, especially when contrasted with Solar Industries, which has a PE ratio of 95.31, and Gujarat Fluoroch, with a PE of 57.85, both of which are considered very expensive. Despite the recent grade change, Resonance Speciality has shown a strong return over the long term, with a 10-year return of 383.89%, although it has underperformed against the Sensex in the shorter term, particularly with a year-to-date return of -2.57% compared to the Sensex's 8.72%. Overall, the company remains fairly valued in the current market context....

Why is Resonance Speci. falling/rising?

2025-11-06 22:37:48

As of 06-Nov, Resonance Specialities Ltd is experiencing a decline in its stock price, currently at Rs 90.86, which reflects a decrease of Rs 4.04 or 4.26%. The stock has been underperforming, having lost 7.15% over the last three days and is trading below all key moving averages, indicating a bearish trend. Additionally, the stock's performance over the past week shows a decline of 6.21%, and it has underperformed its sector by 3.14% today. The delivery volume has also decreased significantly, falling by 28.5% against the 5-day average, suggesting reduced investor participation. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, the Sensex has shown a modest decline of 1.30% over the past week, which contrasts with Resonance Specialities' sharper drop. While the benchmark has gained 1.86% ...

Is Resonance Speci. overvalued or undervalued?

2025-11-06 08:09:24

As of 4 November 2025, the valuation grade for Resonance Speci. has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 14.64, an EV to EBITDA of 7.57, and a PEG ratio of 0.23, all of which suggest that the stock is trading at a discount relative to its earnings growth potential. In comparison to its peers, Resonance Speci. stands out favorably against companies like Godrej Industries, which has a PE ratio of 36.97 and an EV to EBITDA of 29.44, and Solar Industries, which is deemed very expensive with a PE ratio of 97.69. Despite recent underperformance relative to the Sensex, with a YTD return of -2.27% compared to the Sensex's 6.81%, the attractive valuation metrics imply that Resonance Speci. may present a compelling investment opportunity moving forward....

View All News